In this video, Professor Steve Conlan from Swansea University describes the development of a new technology for high-throughput epigenetics enabling fast and accurate results. Personalized medicine and companion diagnostics using epigenetic targets and biomarkers is a rapidly emerging area that shows great promise in the fight against cancer.